This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PDL BioPharma Inc (PDLI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 291.38M 94.30M 131.21M 168.54M
Receivables 57.90M 313.00K 7.87M 600.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 355.90M 107.70M 182.98M 233.51M
Property, Plant & Equipment, Gross 9.24M 9.19M 9.19M 9.14M
Accumulated Depreciation & Depletion 9.18M 9.15M 9.13M 9.12M
Property, Plant & Equipment, Net 62.00K 41.00K 59.00K 22.00K
Intangibles 259.24M 235.68M 0.00 0.00
Other Non-Current Assets 313.35M 193.84M 92.37M 24.46M
Total Non-Current Assets 606.45M 436.26M 96.98M 35.96M
Liabilities & Shareholder Equity
Total Assets 962.35M 543.96M 279.97M 269.47M
Accounts Payable 318.00K 287.00K 1.07M 528.00K
Short Term Debt 0.00 74.40M 0.00 0.00
Other Current Liabilities 4.33M 59.00K 287.00K 0.00
Total Current Liabilities 187.98M 407.42M 10.47M 133.01M
Long Term Debt 276.23M 0.00 309.95M 316.62M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 37.70M 23.04M 27.66M 24.12M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 313.93M 23.04M 337.61M 340.74M
Total Liabilities 501.91M 430.47M 348.09M 473.74M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 460.44M 113.49M -68.12M -204.27M
Common Par 1.62M 1.40M 1.40M 1.40M
Additional Paid In Capital -119.87M -233.17M -234.07M -161.75M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 575.74M 350.15M 169.63M -42.04M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 2.95M -4.89M -5.09M -1.88M
Total Capitalization 736.66M 113.49M 241.83M 112.34M
Total Equity 460.44M 113.49M -68.12M -204.27M
Total Liabilities & Stock Equity 962.35M 543.96M 279.97M 269.47M
Total Common Shares Outstanding 162.19M 139.94M 139.82M 139.68M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 158.22M 139.84M 139.71M 139.66M
Diluted Weighted Shares Outstanding 173.11M 159.34M 146.40M 177.44M
Number of Employees 10 10 10 10
Number of Part-Time Employees 0 0 0 0

PDLI PDL BioPharma Inc

Chart of PDLI

Analysts Ratings for PDLI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

PDLI Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs